Gene therapy developer CRISPR Therapeutics AG (CRSP) is navigating some regulatory and commercial dynamics. Its flagship gene ...

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

Tuesday afternoon's $69 billion sale of 2-year Treasury notes was met with below-average bidding by nondealers. The auction produced a tail of a half basis point amid soft demand and nondealer bidding ...

We recently published a list of 10 Best Stocks to Buy According to Billionaire Chris Rokos. In this article, we are going to ...

U.S. government debt was mostly rallying as of Tuesday morning, led by interest in 20- and 30-year bonds, amid a dearth of major data releases and as traders remain attuned to any further attacks by ...

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.

California's high unemployment rate and job losses in private industries predated President Trump's global trade crusade.

Bath & Body Works does a majority of its manufacturing in the United States, so tariff policies won’t significantly affect ...

CMOC Singapore will acquire Canadian miner Lumina Gold for a total equity value of approximately C$581m ($419.3m).

Alnylam and BridgeBio are competing for people who are switching from Pfizer’s blockbuster ATTR amyloidosis drug tafamidis while all three companies are fighting for new patients.

Novo Nordisk filed for approval of an oral, 25-mg formulation of semaglutide “earlier this year,” according to a company spokesperson.